Side effects and acceptability of Implanon®: A pilot study conducted in eastern Turkey

Abstract

Mainly because of irregular bleeding, the discontinuation rate of Implanon at 6 months among the women in this region is high (19.5%).

Etonogestrel contraceptive implant (Implanon): analysis of patient compliance and adverse effects in the breastfeeding period

“…No unexplained adverse maternal effects have been reported during use of Implanon® in the postpartum period (11). In clinical trials, the most common non-menstrual side effects experienced when wearing an implant are reported to range from 15-25% (12)(13)(14)(15). In our study, the most frequent non-menstrual side effects experienced when wearing an implant, are; weight increases, anxiety, breast tenderness and headache (6.5 to 16%).…”

“…In terms of mood changes and weight gain, they also reported a significantly increased frequency of headache, nausea and dizziness at the end of the study. Probably these differencescan be related to a different patient profile of healthy sexually active women and the short period of their study (12). The main reason for removal during the breastfeeding period was the bleeding problem (frequent/prolonged bleeding).…”

Etonogestrel Implant (Implanon); Frequency of Adverse Effects Caused by Implantation of Singlerod Etonogestrel Implant (Implanon) in Females Seeking Birth Spacing After Delivery of Previous Pregnancy

“…41.5%), however mastalgia expanded altogether as it was accounted for by five beforehand unaffected participants (12.2%). 13 These discoveries are likewise equivalent to our review. As Implanon contains no estrogen, the most widely recognized adverse occasions related with its utilization are identified with changes in patterns of bleeding or progestin-related hormonal side effects.…”

“…8,12 The agreeableness of adverse impacts of a given prophylactic/ contraceptive strategy impacts its consistence rates and this can shift in various geographic regions. 13 Preventative strategies and contraceptive methods, including inserts or implants, don't counteract normal side effects and adverse health occasions that a great many people understanding. It is troublesome, along these lines, to choose whether or not the event of manifestations or adverse occasions that are regular can be ascribed to utilization of a preventative strategy or to figure out whether a given technique changes the probability of their occurrence.…”

Drug-Induced Acneiform Eruptions

“…A previous study demonstrated that 26.8% of women who used contraceptive etonogestrel implants developed acne [14]. Additionally, women who were placed a levonorgestrel-releasing intrauterine device developed inlammatory papular lesions 1-3 months after the procedure [15].…”